171 related articles for article (PubMed ID: 8263684)
1. Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapy.
Dillon PW; Fox PS; Berg CJ; Cardella JF; Krummel TM
J Pediatr Surg; 1993 Oct; 28(10):1264-8; discussion 1268-9. PubMed ID: 8263684
[TBL] [Abstract][Full Text] [Related]
2. Caval thrombolysis in neonates using low doses of recombinant human tissue-type plasminogen activator.
Anderson BJ; Keeley SR; Johnson ND
Anaesth Intensive Care; 1991 Feb; 19(1):22-7. PubMed ID: 1901463
[TBL] [Abstract][Full Text] [Related]
3. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy in preterm infants: Fifteen-year experience.
Grizante-Lopes P; Garanito MP; Celeste DM; Krebs VLJ; Carneiro JDA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28544. PubMed ID: 32710708
[TBL] [Abstract][Full Text] [Related]
5. Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator.
Chang R; Horne MK; Mayo DJ; Doppman JL
J Vasc Interv Radiol; 1996; 7(6):845-51. PubMed ID: 8951751
[TBL] [Abstract][Full Text] [Related]
6. Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator.
Greenberg S; Kosinski R; Daniels J
Chest; 1991 May; 99(5):1298-301. PubMed ID: 1902161
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis with low dose tissue plasminogen activator.
Doyle E; Britto J; Freeman J; Munro F; Morton NS
Arch Dis Child; 1992 Dec; 67(12):1483-4. PubMed ID: 1489229
[TBL] [Abstract][Full Text] [Related]
8. Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.
Gu S; Ducas J; Patton JN; Greenberg D; Prewitt RM
Chest; 1992 Jun; 101(6):1684-90. PubMed ID: 1600792
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of acute inferior vena cava and unilateral renal vein thrombosis by local infusion of recombinant tissue plasminogen activator.
Lam KK; Lui CC
Am J Kidney Dis; 1998 Dec; 32(6):1075-9. PubMed ID: 9856527
[TBL] [Abstract][Full Text] [Related]
10. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
Schranz D; Haugwitz D; Zimmer B; Schumacher R
Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
[TBL] [Abstract][Full Text] [Related]
11. In utero arterial embolism from renal vein thrombosis with successful postnatal thrombolytic therapy.
Duncan BW; Adzick NS; Longaker MT; Edwards JR; Nelson RM; Koerper MA
J Pediatr Surg; 1991 Jun; 26(6):741-3. PubMed ID: 1941470
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of adjunctive intrathrombic heparin with pulse spray thrombolysis in rabbit inferior vena cava thrombosis.
Valji K; Bookstein JJ
Invest Radiol; 1992 Nov; 27(11):912-7. PubMed ID: 1464509
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.
Chen HA; Ma YH; Hsu TY; Chen JP
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.
El-Segaier M; Khan MA; Khan ZU; Momenah T; Galal MO
Pediatr Cardiol; 2015 Dec; 36(8):1582-7. PubMed ID: 25991571
[TBL] [Abstract][Full Text] [Related]
15. Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis.
Tarry WC; Makhoul RG; Tisnado J; Posner MP; Sobel M; Lee HM
Ann Vasc Surg; 1994 Nov; 8(6):583-90. PubMed ID: 7865398
[TBL] [Abstract][Full Text] [Related]
16. Treatment of critical limb ischemia using ultrasound-enhanced thrombolysis (PARES Trial): final results.
Wissgott C; Richter A; Kamusella P; Steinkamp HJ
J Endovasc Ther; 2007 Aug; 14(4):438-43. PubMed ID: 17696616
[TBL] [Abstract][Full Text] [Related]
17. [Local thrombolysis in peripheral arterial occlusion].
Hess H
Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
[TBL] [Abstract][Full Text] [Related]
19. Successful Treatment of Transplant Renal Artery Thrombosis With Systemic Infusion of Recombinant-Tissue-Plasminogen Activator After Renal Transplant.
Yoshida T; Yanishi M; Nakamoto T; Sugi M; Kinoshita H; Matsuda T
Exp Clin Transplant; 2017 Oct; 15(5):571-573. PubMed ID: 26325476
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization.
Tsetis DK; Kochiadakis GE; Hatzidakis AA; Skalidis EI; Chryssou EG; Tritou IN; Vardas PE; Gourtsoyiannis NC
Cardiovasc Intervent Radiol; 2002; 25(1):36-41. PubMed ID: 11907772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
